WHO: Andes Hantavirus Not a COVID-19-Level Threat
Key Summary Andes hantavirus has drawn attention following a cruise ship-linked outbreak, prompting comparisons with COVID-19. Scientific analysis shows the
Read MoreKey Summary Andes hantavirus has drawn attention following a cruise ship-linked outbreak, prompting comparisons with COVID-19. Scientific analysis shows the
Read MoreKey Highlights Two candidate Tuberculosis vaccines, VPM1002 and Immuvac, demonstrated strong safety profiles No overall protection against pulmonary TB or
Read MoreKey Takeaways Experimental antibiotics disrupt a vital protein degradation system in Mycobacterium tuberculosis Findings explain distinct mechanisms of ecumicin, ilamycin,
Read MoreKey Takeaways (At a Glance) Infection rates of Trypanosoma cruzi in kissing bugs have risen sharply in the U.S. Southwest.
Read MoreA Harvard Medical School-led clinical trial has identified three highly effective drug regimens for drug-resistant tuberculosis (TB), marking a significant
Read MoreProtein Guard Mechanism – Researchers discovered a defense mechanism for a protein that kills bacteria in infected cells. The University
Read More